ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Torontodominion Bank Issuer Callable Contingent Interest Worst

Torontodominion Bank Issuer Callable Contingent Interest Worst (ABMHGXX)

0.00
0.00
(0.00%)
Cerrado 14 Enero 3:00PM
0.00
0.00
( 0.00% )

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
-
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
-
Precio de Apertura
-
Hora
Última hora de negociación
-
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

ABMHGXX Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000FU
40000000FU
120000000FU
260000000FU
520000000FU
1560000000FU
2600000000FU

ABMHGXX - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Torontodominion Bank Iss...?
El precio actual de las acciones de Torontodominion Bank Iss... es US$ 0.00
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Torontodominion Bank Iss...?
Torontodominion Bank Iss... ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
STAFStaffing 360 Solutions Inc
US$ 4.37
(92.09%)
5.09M
PIIIP3 Partners Inc
US$ 0.345
(60.54%)
21.1M
NMHINatures Miracle Holding Inc
US$ 1.69
(49.56%)
597.25k
ADDColor Star Technology Company Ltd
US$ 2.45
(33.88%)
2.84M
LGCBLinkage Global Inc
US$ 0.50
(28.87%)
2
BCOW1895 Bancorp of Wisconsin Inc
US$ 7.51
(-24.45%)
2
SMXSMX Security Matters Public Company
US$ 0.20
(-23.08%)
844.51k
ATPCAgape ATP Corporation
US$ 1.53
(-22.34%)
48.56k
CTRNCiti Trends Inc
US$ 20.51
(-21.99%)
1
PHIOPhio Pharmaceuticals Corporation
US$ 5.17
(-21.67%)
276.8k
PIIIP3 Partners Inc
US$ 0.345
(60.54%)
21.1M
LAESSEALSQ Corporation
US$ 3.84
(14.63%)
8.89M
GCTKGlucoTrack Inc
US$ 0.136
(-9.15%)
5.83M
STAFStaffing 360 Solutions Inc
US$ 4.37
(92.09%)
5.09M
SVMHSRIVARU Holding Ltd
US$ 0.028
(-20.23%)
4.87M
Investor2014 Investor2014 9 minutos hace
That is still the "In Press, Corrected Proof"!

What are corrected proofs?
Corrected proofs are Articles in Press that contain the author’s corrections. Final citation details (e.g., volume and/or issue number, publication year, and page numbers) still need to be added and the t
AVXL
diggitydoodle diggitydoodle 12 minutos hace
This week has started as a clone of the past 3 years. This ticker stuck at worthless, with a little up & down action to trips 1 and back down again.
Behind the scenes scenarios and predictions mean nothing...unless the news comes from the great CEO himself. But, he can't even file fins on tim
RNVA
Golden Cross Golden Cross 18 minutos hace
$ILLR Many Reasons To Like Triller Now!

~ Launch of Triller 5.0 App.
~ New Streaming Acquisition News Soon
~ Multiple Revenue Streams.
~ New CEO of Triller App is former TikTok executive Sean Kim.
~ TikTok US ban starts 1-19, 2025. Federal court just upheld
ILLR
Golden Cross Golden Cross 19 minutos hace
💎 $ILLR Many Reasons To Like Triller Now⬇️

~ Launch of Triller 5.0 App.
~ New Streaming Acquisition News Soon
~ Multiple Revenue Streams.
~ New CEO of Triller App is former TikTok executive Sean Kim.
~ TikTok US ban starts 1-19, 2025. Federal cour
ILLR
kspar1 kspar1 21 minutos hace
Wow! I had no idea the JPM conference in San Francisco is as energetic as this link reads, including the partnership announcements. Will be fun to see how Anavex is positioned. The conference supposed to generate $92M for the city.
https://www.fiercebiotech.com/biotech/jpm25-day-1-fierce-bio
JPM
Frankestin Frankestin 22 minutos hace
Truist Securities raises PT to $180 from $150 😮
The next two weeks will be eventful
AXS-07, a candidate for the acute treatment of migraines, with expectations for regulatory approval
NDA for AXS-14 for fibromyalgia... maybe yes or maybe no
AXSM
Number sleven Number sleven 26 minutos hace
https://www.courtlistener.com/docket/59859757/dr-reddys-laboratories-inc-v-amarin-pharma-inc/?page=2
Sleven,
AMRN
price_and_volume price_and_volume 30 minutos hace
"Right news" gonna get $175-350MM market cap? LOL!

Omg what a maroon.
VXIT
The Danish Dude The Danish Dude 30 minutos hace
Nice and interesting analysis, but completely irrelevant >!

I fed ChatGPT the following five comments regarding this analysis and it disagrees with you.

I saw these comments regarding how MHRA approves or rejects medecines at mhra meetings

1
NWBO
lakers17 lakers17 31 minutos hace
MTC back to $96,000 after hitting $89, 200s yesterday. Cryptos I added to in the last couple of days were BOBO, PAI, OTTO and CLUSTR. RING AI looking better. Boom or bust for me.
MTC
Golden Cross Golden Cross 34 minutos hace
Loading Zone Here! $ASII
ASII
Hi_Lo Hi_Lo 43 minutos hace
Where is the CSE press release filing?

TWOH has been halted for more than a week now and the CSE press release is still missing.

Could the run up before the halt be the problem?

Could some people have been tipped off before the run up?

Coul
TWOH
SkeBallLarry SkeBallLarry 51 minutos hace
https://scontent-mia3-1.xx.fbcdn.net/v/t39.30808-6/473323273_992397186268896_4170433101098362110_n.jpg?_nc_cat=100&ccb=1-7&_nc_sid=833d8c&_nc_ohc=UebR9WKXEXsQ7kNvgELlMGV&_nc_zt=23&_nc_ht=scontent-mia3-1.xx&_nc_gid=AvB9U-Cb1bfWGguzkXzMzar&oh=00_AYDqG-tA0ScuUz90hSjz11X1LQL5aezyuhOfdBXmp9pGuQ&oe=678C04
Dodger1 Dodger1 52 minutos hace
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175652942 I Miss Real
AABB
jondoeuk jondoeuk 55 minutos hace
NEUK201-00* is being tested in advanced/metastatic solid tumours at a single site.

https://i.postimg.cc/fyWcxcwj/download.png

* It could be an iNK with just a high-affinity non-cleavable CD16(a) receptor, but this comes from a Chinese site that has under
HPQ
marcis marcis 57 minutos hace
I was just thinking the same thing

Go bother those serial OTC stock hijackers
( we know them all well ) that’s been doing LOI mergers, asset ( no asset ) transfers for years with never a real company.
( not you Prophet, to the shills )
Save those investors
RDAR
No-Quarter No-Quarter 57 minutos hace
Good to know, thx!
LetGoodTimesRoll LetGoodTimesRoll 58 minutos hace
The criminality surrounding BLUE Sheets data is rampant...

https://www.sec.gov/newsroom/press-releases/2025-5?utm_medium=email&utm_source=govdelivery
FOXO
Seminole Red Seminole Red 58 minutos hace
https://scontent-mia3-2.xx.fbcdn.net/v/t39.30808-6/472742874_1004087688423643_1614366062036311373_n.jpg?_nc_cat=1&ccb=1-7&_nc_sid=833d8c&_nc_ohc=nfcGrMsEIhAQ7kNvgF3nw1U&_nc_zt=23&_nc_ht=scontent-mia3-2.xx&_nc_gid=AZgGdnGS_3zIT8EnJ2PY5KX&oh=00_AYA_PYWQyRmy2OxdvryhKxL8uHQSf69FZtEDZ_CZJ06VFQ&oe=678BF3D
Bubae Bubae 58 minutos hace
New shares flying everywhere from the looks of the filings. Form 144 filed on January 10th by Atlas Merchant Capital LLC intent to sell 1,241,144 shares. approximate date of sale listed as 01/10/2025. Robert E. Diamond, Triller Chairman of the Board, Chief Executive Officer of Atlas Merchant Capita
ILLR
meshcan meshcan 1 hora hace
Yes, hence I was saying the really numbers will be in a couple quarters from now, August CC will be two full quarters that we have Vyvanse sell numbers.

CC: NASDAC2020
ELTP
PlaneReflection PlaneReflection 1 hora hace
Remember when you said it won't pass $2 again?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174119656

Please say it won't pass $10 again, $30 again and it'll never be over $200. Thanks.
FNMA
eagle8 eagle8 1 hora hace
ATLnsider
@ATLnsider
Global future for $NWBO #DCVax dendritic cell vaccine platform could be unlimited if efficacy is proven to be tumor & tissue agnostic for all solid tumor cancers & when combined with checkpoint inhibitors can also effectively treat all blood or liquid cancers. NWBi
NWBO